30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Galectin Therapeutics Inc (GALT)

Track

Over the last 90 days, Galectin Therapeutics Inc. has seen two insider transactions totaling $27,261.03 in sales. Notably, Jamil Khurram, an officer, made proposed and planned sales. The company's stock has experienced a 11.4% increase in the past 90 days, trading near its 52-week low.
Stock chart
Ticker: GALT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Jamil Khurram
Officer
1 sale — total 100,000 USD
Proposed sale 23 Jun 2026
Value US$113,271.67 | Price 197.17 | Shares 34,213
Planned sale 26 May 2026
Value US$3,863,853.99 | Price 207.56 | Shares 51,280
Buy 6 Feb 2026
Value US$810.00 | Price 2.70 | Shares 300
Planned sale 6 Jan 2026
Value US$78,204.98 | Price 3.65 | Shares 21,446
Planned sale 6 Jan 2026
Value US$74,695.11 | Price 3.67 | Shares 20,354
Planned sale 6 Jan 2026
Value US$134,853.29 | Price 3.58 | Shares 37,698
Planned sale 5 Jan 2026
Value US$99,407.85 | Price 3.90 | Shares 25,499
Planned sale 5 Jan 2026
Value US$100,298.19 | Price 3.90 | Shares 25,732
Planned sale 5 Jan 2026
Value US$108,342.24 | Price 3.91 | Shares 27,731
Proposed sale 2 Jan 2026
Value US$1,836,640.00 | Price 4.16 | Shares 441,500
Planned sale 2 Jan 2026
Value US$54,789.22 | Price 4.20 | Shares 13,055
Proposed sale 2 Jan 2026
Value US$252,000.00 | Price 4.20 | Shares 60,000
Planned sale 2 Jan 2026
Value US$58,394.28 | Price 4.20 | Shares 13,914
Proposed sale 2 Jan 2026
Value US$252,000.00 | Price 4.20 | Shares 60,000
Proposed sale 2 Jan 2026
Value US$593,065.00 | Price 4.20 | Shares 141,206
Planned sale 2 Jan 2026
Value US$77,938.77 | Price 4.20 | Shares 18,571
Proposed sale 2 Jan 2026
Value US$352,800.00 | Price 4.20 | Shares 84,000
Planned sale 31 Dec 2025
Value US$33,089.06 | Price 4.07 | Shares 8,125
Buy 23 Dec 2025
Value US$2,611.00 | Price 3.73 | Shares 700
Buy 23 Dec 2025
Value US$2,611.00 | Price 3.73 | Shares 700
Buy 23 Dec 2025
Value US$19,514.00 | Price 3.55 | Shares 5,500
Planned sale 17 Dec 2025
Value US$55,241.42 | Price 7.06 | Shares 7,829
Proposed sale 17 Dec 2025
Value US$282,244.00 | Price 7.06 | Shares 40,000
Planned sale 17 Dec 2025
Value US$33,120.83 | Price 7.04 | Shares 4,706
Planned sale 17 Dec 2025
Value US$139,303.13 | Price 7.04 | Shares 19,793
Planned sale 17 Dec 2025
Value US$59,840.00 | Price 7.04 | Shares 8,500
Planned sale 17 Dec 2025
Value US$45,499.52 | Price 7.04 | Shares 6,463
Planned sale 17 Dec 2025
Value US$31,532.16 | Price 7.04 | Shares 4,479
Proposed sale 17 Dec 2025
Value US$151,212.00 | Price 7.04 | Shares 21,479
Proposed sale 17 Dec 2025
Value US$172,222.56 | Price 6.97 | Shares 24,706
Sale 16 Dec 2025
Value US$204,335.46 | Price 6.66 | Shares 30,681
Planned sale 15 Dec 2025
Value US$53,027.10 | Price 6.30 | Shares 8,417
Proposed sale 15 Dec 2025
Value US$52,541.90 | Price 6.24 | Shares 8,417
Planned sale 12 Dec 2025
Value US$124,181.28 | Price 6.27 | Shares 19,793
Proposed sale 12 Dec 2025
Value US$122,993.00 | Price 6.21 | Shares 19,793
Proposed sale 12 Dec 2025
Value US$122,993.00 | Price 6.21 | Shares 19,793
Planned sale 9 Dec 2025
Value US$105,206.14 | Price 6.27 | Shares 16,790
Proposed sale 9 Dec 2025
Value US$104,198.00 | Price 6.21 | Shares 16,790
Planned sale 8 Dec 2025
Value US$120,040.00 | Price 6.00 | Shares 20,000
Planned sale 8 Dec 2025
Value US$210,665.00 | Price 6.02 | Shares 35,000
Planned sale 8 Dec 2025
Value US$148,650.00 | Price 5.95 | Shares 25,000
Planned sale 8 Dec 2025
Value US$119,240.00 | Price 5.96 | Shares 20,000
Planned sale 8 Dec 2025
Value US$119,240.00 | Price 5.96 | Shares 20,000
Planned sale 8 Dec 2025
Value US$208,250.00 | Price 5.95 | Shares 35,000
Planned sale 8 Dec 2025
Value US$24,020.00 | Price 6.01 | Shares 4,000
Proposed sale 8 Dec 2025
Value US$957,180.00 | Price 6.02 | Shares 159,000
Sale 3 Dec 2025
Value US$687,600.00 | Price 5.73 | Shares 120,000
Sale 2 Dec 2025
Value US$164,100.00 | Price 5.47 | Shares 30,000
Planned sale 18 Nov 2025
Value US$113,320.83 | Price 6.22 | Shares 18,210
Planned sale 18 Nov 2025
Value US$174,866.30 | Price 6.22 | Shares 28,100
Planned sale 18 Nov 2025
Value US$41,722.91 | Price 6.15 | Shares 6,783
Planned sale 17 Nov 2025
Value US$14,011.64 | Price 6.03 | Shares 2,323
Planned sale 17 Nov 2025
Value US$118,830.52 | Price 6.03 | Shares 19,701
Planned sale 17 Nov 2025
Value US$57,819.88 | Price 6.03 | Shares 9,586
Planned sale 17 Nov 2025
Value US$94,642.91 | Price 6.04 | Shares 15,680
Planned sale 13 Nov 2025
Value US$88,887.50 | Price 5.47 | Shares 16,250
Planned sale 13 Nov 2025
Value US$227,005.00 | Price 5.47 | Shares 41,500
Planned sale 13 Nov 2025
Value US$227,005.00 | Price 5.47 | Shares 41,500
Planned sale 13 Nov 2025
Value US$119,612.49 | Price 5.47 | Shares 21,867
Proposed sale 13 Nov 2025
Value US$660,088.00 | Price 5.45 | Shares 121,117
Sale 11 Nov 2025
Value US$210,000.00 | Price 5.25 | Shares 40,000
Planned sale 10 Nov 2025
Value US$11,252.22 | Price 6.03 | Shares 1,867
Planned sale 10 Nov 2025
Value US$10,467.73 | Price 6.03 | Shares 1,736
Planned sale 10 Nov 2025
Value US$10,094.56 | Price 6.03 | Shares 1,675
Planned sale 10 Nov 2025
Value US$11,321.36 | Price 6.02 | Shares 1,880
Planned sale 5 Nov 2025
Value US$1,200.00 | Price 6.00 | Shares 200
Planned sale 5 Nov 2025
Value US$1,200.00 | Price 6.00 | Shares 200
Planned sale 5 Nov 2025
Value US$1,200.00 | Price 6.00 | Shares 200
Planned sale 5 Nov 2025
Value US$1,200.00 | Price 6.00 | Shares 200
Planned sale 4 Nov 2025
Value US$65,197.87 | Price 6.07 | Shares 10,741
Planned sale 4 Nov 2025
Value US$54,472.18 | Price 6.07 | Shares 8,974
Planned sale 4 Nov 2025
Value US$54,107.98 | Price 6.07 | Shares 8,914
Planned sale 4 Nov 2025
Value US$87,529.40 | Price 6.07 | Shares 14,420
Planned sale 3 Nov 2025
Value US$7,512.50 | Price 6.01 | Shares 1,250
Planned sale 3 Nov 2025
Value US$7,572.60 | Price 6.01 | Shares 1,260
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-23 2026-06-23 PrS Proposed sale
Jamil Khurram

Officer

Officer
34,213
197.17
US$113,272 		34,213 197.17 US$113,272
2026-05-28 2026-05-26 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
51,280 +18.4%
207.56
US$3,863,854 		51,280 +18.4% 207.56 US$3,863,854
2026-02-09 2026-02-06 B Purchase
4.1
ELDRED KARY
Non-Executive Director
10,540 +3.9%
10.39
US$495,747 		10,540 +3.9% 10.39 US$495,747
2026-01-06 2026-01-06 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
21,446 -100.0%
3.65
US$78,205 		21,446 -100.0% 3.65 US$78,205
2026-01-06 2026-01-06 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
20,354 -72.8%
3.67
US$74,695 		20,354 -72.8% 3.67 US$74,695
2026-01-06 2026-01-06 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
37,698 -4.3%
3.58
US$134,853 		37,698 -4.3% 3.58 US$134,853
2026-01-06 2026-01-05 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
25,499 -54.3%
3.90
US$99,408 		25,499 -54.3% 3.90 US$99,408
2026-01-06 2026-01-05 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
25,732 -47.9%
3.90
US$100,298 		25,732 -47.9% 3.90 US$100,298
2026-01-06 2026-01-05 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
27,731 -3.1%
3.91
US$108,342 		27,731 -3.1% 3.91 US$108,342
2026-01-06 2026-01-02 PrS Proposed sale
2.9
Shlevin Harold H.

Director

Non-Executive Director
441,500
4.16
US$1,836,640 		441,500 4.16 US$1,836,640
2026-01-06 2026-01-02 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
13,055 -21.8%
4.20
US$54,789 		13,055 -21.8% 4.20 US$54,789
2026-01-06 2026-01-02 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
13,914 -20.6%
4.20
US$58,394 		13,914 -20.6% 4.20 US$58,394
2026-01-06 2026-01-02 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
18,571 -2.0%
4.20
US$77,939 		18,571 -2.0% 4.20 US$77,939
2026-01-05 2026-01-02 PrS Proposed sale
2.3
CALLICUTT JACK W

Officer

Officer
60,000
4.20
US$252,000 		60,000 4.20 US$252,000
2026-01-02 2026-01-02 PrS Proposed sale
2.3
LEWIS JOEL

Officer

Officer
84,000
4.20
US$352,800 		84,000 4.20 US$352,800
2026-01-02 2026-01-02 PrS Proposed sale
Jamil Khurram

Officer

Officer
60,000
4.20
US$252,000 		60,000 4.20 US$252,000
2026-01-02 2026-01-02 PrS Proposed sale
2.3
CALLICUTT JACK W

Officer

Officer
141,206
4.20
US$593,065 		141,206 4.20 US$593,065
2026-01-05 2025-12-31 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
8,125 -100.0%
4.07
US$33,089 		8,125 -100.0% 4.07 US$33,089
2025-12-23 2025-12-23 B Purchase
4.1
ELDRED KARY
Non-Executive Director
700 +1.1%
3.73
US$2,611 		700 +1.1% 3.73 US$2,611
2025-12-23 2025-12-23 B Purchase
3.2
FREEMAN KEVIN D
Non-Executive Director
5,500 +11.1%
3.55
US$19,514 		5,500 +11.1% 3.55 US$19,514
2025-12-23 2025-12-23 B Purchase
4.1
ELDRED KARY
Non-Executive Director
700 +1.1%
3.73
US$2,611 		700 +1.1% 3.73 US$2,611
2025-12-19 2025-12-17 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
7,829 -0.9%
7.06
US$55,241 		7,829 -0.9% 7.06 US$55,241
2025-12-19 2025-12-17 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
4,706 -42.0%
7.04
US$33,121 		4,706 -42.0% 7.04 US$33,121
2025-12-19 2025-12-17 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
19,793 -63.9%
7.04
US$139,303 		19,793 -63.9% 7.04 US$139,303
2025-12-19 2025-12-17 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
8,500 -100.0%
7.04
US$59,840 		8,500 -100.0% 7.04 US$59,840
2025-12-19 2025-12-17 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
6,463 -100.0%
7.04
US$45,500 		6,463 -100.0% 7.04 US$45,500
2025-12-19 2025-12-17 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
4,479 -100.0%
7.04
US$31,532 		4,479 -100.0% 7.04 US$31,532
2025-12-17 2025-12-17 PrS Proposed sale
Jamil Khurram

Officer

Officer
21,479
7.04
US$151,212 		21,479 7.04 US$151,212
2025-12-17 2025-12-17 PrS Proposed sale
2.3
LEWIS JOEL

Officer

Officer
40,000
7.06
US$282,244 		40,000 7.06 US$282,244
2025-12-17 2025-12-17 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
24,706
6.97
US$172,223 		24,706 6.97 US$172,223
2025-12-18 2025-12-16 S Sale
4.3
10X Fund, L.P.
Large shareholder
30,681 -0.5%
6.66
US$204,335 		30,681 -0.5% 6.66 US$204,335
2025-12-16 2025-12-15 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
8,417 -42.9%
6.30
US$53,027 		8,417 -42.9% 6.30 US$53,027
2025-12-15 2025-12-15 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
8,417
6.24
US$52,542 		8,417 6.24 US$52,542
2025-12-16 2025-12-12 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
19,793 -63.9%
6.27
US$124,181 		19,793 -63.9% 6.27 US$124,181
2025-12-15 2025-12-12 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
19,793
6.21
US$122,993 		19,793 6.21 US$122,993
2025-12-12 2025-12-12 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
19,793
6.21
US$122,993 		19,793 6.21 US$122,993
2025-12-10 2025-12-09 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
16,790 -60.0%
6.27
US$105,206 		16,790 -60.0% 6.27 US$105,206
2025-12-09 2025-12-09 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
16,790
6.21
US$104,198 		16,790 6.21 US$104,198
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
20,000 -64.1%
6.00
US$120,040 		20,000 -64.1% 6.00 US$120,040
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
35,000 -75.7%
6.02
US$210,665 		35,000 -75.7% 6.02 US$210,665
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
25,000 -69.0%
5.95
US$148,650 		25,000 -69.0% 5.95 US$148,650
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
20,000 -64.1%
5.96
US$119,240 		20,000 -64.1% 5.96 US$119,240
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
20,000 -64.1%
5.96
US$119,240 		20,000 -64.1% 5.96 US$119,240
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
35,000 -75.7%
5.95
US$208,250 		35,000 -75.7% 5.95 US$208,250
2025-12-10 2025-12-08 PlS Planned sale
2.9
Shlevin Harold H.
Non-Executive Director
4,000 -26.3%
6.01
US$24,020 		4,000 -26.3% 6.01 US$24,020
2025-12-08 2025-12-08 PrS Proposed sale
2.9
HAROLD SHLEVIN

DIRECTOR

Non-Executive Director
159,000
6.02
US$957,180 		159,000 6.02 US$957,180
2025-12-04 2025-12-03 S Sale
4.3
10X Fund, L.P.
Large shareholder
120,000 -2.1%
5.73
US$687,600 		120,000 -2.1% 5.73 US$687,600
2025-12-04 2025-12-02 S Sale
4.3
10X Fund, L.P.
Large shareholder
30,000 -0.5%
5.47
US$164,100 		30,000 -0.5% 5.47 US$164,100
2025-11-19 2025-11-18 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
18,210 -70.5%
6.22
US$113,321 		18,210 -70.5% 6.22 US$113,321
2025-11-19 2025-11-18 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
28,100 -78.7%
6.22
US$174,866 		28,100 -78.7% 6.22 US$174,866
2025-11-19 2025-11-18 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
6,783 -0.8%
6.15
US$41,723 		6,783 -0.8% 6.15 US$41,723
2025-11-19 2025-11-17 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
2,323 -23.4%
6.03
US$14,012 		2,323 -23.4% 6.03 US$14,012
2025-11-19 2025-11-17 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
19,701 -72.1%
6.03
US$118,831 		19,701 -72.1% 6.03 US$118,831
2025-11-19 2025-11-17 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
9,586 -55.7%
6.03
US$57,820 		9,586 -55.7% 6.03 US$57,820
2025-11-19 2025-11-17 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
15,680 -1.8%
6.04
US$94,643 		15,680 -1.8% 6.04 US$94,643
2025-11-14 2025-11-13 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
16,250 -78.4%
5.47
US$88,888 		16,250 -78.4% 5.47 US$88,888
2025-11-14 2025-11-13 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
41,500 -90.3%
5.47
US$227,005 		41,500 -90.3% 5.47 US$227,005
2025-11-14 2025-11-13 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
41,500 -90.3%
5.47
US$227,005 		41,500 -90.3% 5.47 US$227,005
2025-11-14 2025-11-13 PlS Planned sale
Jamil Khurram

Chief Medical Officer

Officer
21,867 -83.0%
5.47
US$119,612 		21,867 -83.0% 5.47 US$119,612
2025-11-13 2025-11-13 PrS Proposed sale
Jamil Khurram

Officer

Officer
121,117
5.45
US$660,088 		121,117 5.45 US$660,088
2025-11-12 2025-11-11 S Sale
4.3
10X Fund, L.P.
Large shareholder
40,000 -0.7%
5.25
US$210,000 		40,000 -0.7% 5.25 US$210,000
2025-11-12 2025-11-10 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
1,867 -0.2%
6.03
US$11,252 		1,867 -0.2% 6.03 US$11,252
2025-11-12 2025-11-10 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
1,736 -18.6%
6.03
US$10,468 		1,736 -18.6% 6.03 US$10,468
2025-11-12 2025-11-10 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
1,675 -18.0%
6.03
US$10,095 		1,675 -18.0% 6.03 US$10,095
2025-11-12 2025-11-10 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
1,880 -19.8%
6.02
US$11,321 		1,880 -19.8% 6.02 US$11,321
2025-11-07 2025-11-05 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
200 -0.0%
6.00
US$1,200 		200 -0.0% 6.00 US$1,200
2025-11-07 2025-11-05 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
200 -2.6%
6.00
US$1,200 		200 -2.6% 6.00 US$1,200
2025-11-07 2025-11-05 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
200 -2.6%
6.00
US$1,200 		200 -2.6% 6.00 US$1,200
2025-11-07 2025-11-05 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
200 -2.6%
6.00
US$1,200 		200 -2.6% 6.00 US$1,200
2025-11-05 2025-11-04 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
10,741 -58.5%
6.07
US$65,198 		10,741 -58.5% 6.07 US$65,198
2025-11-05 2025-11-04 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
8,974 -54.1%
6.07
US$54,472 		8,974 -54.1% 6.07 US$54,472
2025-11-05 2025-11-04 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
8,914 -53.9%
6.07
US$54,108 		8,914 -53.9% 6.07 US$54,108
2025-11-05 2025-11-04 PlS Planned sale
2.3
LEWIS JOEL

President and CEO

Executive Director
14,420 -1.7%
6.07
US$87,529 		14,420 -1.7% 6.07 US$87,529
2025-11-05 2025-11-03 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
1,250 -14.1%
6.01
US$7,512 		1,250 -14.1% 6.01 US$7,512
2025-11-05 2025-11-03 PlS Planned sale
2.3
CALLICUTT JACK W

Chief Financial Officer

Officer
1,260 -14.2%
6.01
US$7,573 		1,260 -14.2% 6.01 US$7,573
Explore more

More insider trading research around Galectin Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America